13F Portfolios

Madison Avenue Partners, LP — Quarter-over-Quarter 13F Allocation Shifts Q1 2026

In Q1 2026, Madison Avenue Partners, LP initiated 7 new positions, increased allocation to 3 existing positions, trimmed 10 positions, and exited 3 positions entirely. The fund's 13F equity book declined from $2.33B to $2.30B (-1.2% QoQ) . All deltas are sourced from sequential SEC Form 13F-HR filings; share-count changes reflect explicit trading activity, while weight changes can also include price movement. This page lists every position change reported — the portfolio overview shows a summary of the top shifts.

Net Portfolio Value Change

  • $2.33B
    Prior quarter
  • $2.30B
    Current quarter
  • $-0.03B
    Net delta
  • -1.2%
    % change

New Position Initiations Q1 2026

Securities disclosed for the first time in Q1 2026 that were not present in the prior 13F-HR filing.

Madison Avenue Partners, LP new positions in Q1 2026 — first-time disclosed long equity stakes
Company Ticker Initial Allocation Weight History
COUPANG INC CPNG 7.69% History →
ICON PLC (ICLR) ICLR 6.17% History →
APARTMENT INVT & MGMT CO AIV 2.19% Holders →
STAAR SURGICAL CO STAA 1.99% Holders →
PRIMO BRANDS CORPORATION PRMB 1.08% Holders →
DNOW INC DNOW 0.71% Holders →
PAR TECHNOLOGY CORP PAR 0.26% Holders →

Largest Allocation Increases Q1 2026

Largest portfolio-weight increases in existing positions. Share-count delta is shown separately so price-only re-weighting can be distinguished from active adds.

Madison Avenue Partners, LP largest portfolio weight increases in Q1 2026
Company Ticker Δ Weight Δ Shares History
MAGNUM ICE CREAM CO NV MICC +3.06% +78.02% History →
SINCLAIR INC SBGI +0.23% +61.98% Holders →
GALAPAGOS NV GLPG +0.11% +11.39% Holders →

Largest Allocation Reductions Q1 2026

Largest portfolio-weight decreases in existing positions (positions kept open at a lower allocation).

Madison Avenue Partners, LP largest portfolio weight decreases in Q1 2026
Company Ticker Δ Weight Δ Shares History
GLOBUS MEDICAL INC GMED -7.16% -72.66% Holders →
SANDISK CORP/DE SNDK 2.48% -56.84% History →
CENTRAL BANCOMPANY CBC -0.57% -55.23% Holders →
FRANKLIN STR PPTYS CORP FSP -0.06% -52.07% Holders →
WILEY JOHN & SONS INC WLY -0.39% -40.87% Holders →
INDIVIOR PHARMACEUTICALS INC INDV -3.96% -31.29% History →
KEROS THERAPEUTICS INC KROS -0.42% -23.93% Holders →
MAGNERA CORP MAGN -0.50% -10.67% Holders →
BRITISH AMERN TOB PLC BTI -0.12% -8.17% Holders →
SOLVENTUM CORP SOLV -1.44% -5.65% History →

Exited Positions Q1 2026

Positions present in the prior 13F-HR filing that no longer appear in Q1 2026.

Madison Avenue Partners, LP fully exited positions in Q1 2026
Company Ticker Last-Reported Portfolio Weight
SOLSTICE ADVANCED MATLS INC SOLS 5.81%
UNIFIRST CORP UNF 2.52%
WORKIVA INC WK 0.22%

Methodology & FAQ

How Madison Avenue Partners, LP Quarterly Changes Are Computed

Each row above is computed by joining the most recent 13F-HR filing for Madison Avenue Partners, LP against the immediately preceding quarterly filing for the same fund. Portfolio weights are normalized to exclude listed options for comparability. A complete description of the methodology — including how confidential treatment filings are handled and why share count rather than weight is the cleaner trading signal — is documented in the Methodology.

Which positions did Madison Avenue Partners, LP initiate in Q1 2026?

Madison Avenue Partners, LP established 7 new positions in Q1 2026: COUPANG INC (CPNG, 7.69%), ICON PLC (ICLR) (ICLR, 6.17%), APARTMENT INVT & MGMT CO (AIV, 2.19%), STAAR SURGICAL CO (STAA, 1.99%), PRIMO BRANDS CORPORATION (PRMB, 1.08%), DNOW INC (DNOW, 0.71%), PAR TECHNOLOGY CORP (PAR, 0.26%).

Which existing positions saw the largest allocation increases for Madison Avenue Partners, LP in Q1 2026?

The largest portfolio-weight increases in existing positions were: MAGNUM ICE CREAM CO NV (MICC, +3.06% weight, +78.02% shares), SINCLAIR INC (SBGI, +0.23% weight, +61.98% shares), GALAPAGOS NV (GLPG, +0.11% weight, +11.39% shares).

Which positions did Madison Avenue Partners, LP fully exit in Q1 2026?

Madison Avenue Partners, LP fully exited 3 positions in Q1 2026: SOLSTICE ADVANCED MATLS INC (SOLS, last-reported weight 5.81%), UNIFIRST CORP (UNF, last-reported weight 2.52%), WORKIVA INC (WK, last-reported weight 0.22%).

Which existing positions saw the largest allocation reductions for Madison Avenue Partners, LP in Q1 2026?

The largest portfolio-weight reductions in positions kept open were: GLOBUS MEDICAL INC (GMED, -7.16% weight, -72.66% shares), SANDISK CORP/DE (SNDK, 2.48% weight, -56.84% shares), CENTRAL BANCOMPANY (CBC, -0.57% weight, -55.23% shares), FRANKLIN STR PPTYS CORP (FSP, -0.06% weight, -52.07% shares), WILEY JOHN & SONS INC (WLY, -0.39% weight, -40.87% shares), INDIVIOR PHARMACEUTICALS INC (INDV, -3.96% weight, -31.29% shares), KEROS THERAPEUTICS INC (KROS, -0.42% weight, -23.93% shares), MAGNERA CORP (MAGN, -0.50% weight, -10.67% shares), BRITISH AMERN TOB PLC (BTI, -0.12% weight, -8.17% shares), SOLVENTUM CORP (SOLV, -1.44% weight, -5.65% shares).

Do quarter-over-quarter 13F allocation changes constitute explicit trading signals?

No. Quarter-over-quarter changes reflect a combination of active trading and market price movement. A weight increase can result from price appreciation alone, without the manager adding shares. Share-count delta is the cleaner indicator of explicit trading activity.